Cytophage Technologies LtdTSXV:CYTOView on Grey Market
- LAST PRICE0.3000
- TODAY'S CHANGE (%)0.0500 (20.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.2600 / 0.2500
- Day Range
- 52 Week Range
- Volume20,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CYTO |
|---|---|---|
| 12:19 ET | 11000 | 0.27 |
| 12:32 ET | 4500 | 0.28 |
| 01:56 ET | 1000 | 0.285 |
| 02:54 ET | 1000 | 0.29 |
| 03:44 ET | 2500 | 0.3 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cytophage Technologies Ltd | 13.5M | -0.8x | --- |
Kane Biotech Inc | 13.8M | -2.5x | --- |
Preveceutical Medical Inc | 10.8M | -8.5x | --- |
Voyageur Pharmaceuticals Ltd | 9.1M | -6.3x | --- |
Pharmather Holdings Ltd | 19.0M | -9.0x | --- |
Mojave Brands Inc | 7.0M | -5.6x | --- |
Company Information
Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.
Contact Information
- Headquarters
- 26 Henlow BayWINNIPEG, MB, Canada R3Y 1G4
- Phone
- 416-214-4810
- Fax
- ---
Executives
- Independent Chairman of the Board
- Harold Wolkin
- Chief Executive Officer, Director
- Steven Theriault
- Chief Financial Officer, Secretary, Director
- Grant Mccutcheon
- Director
- C. Fraser Elliott
- Director
- Robert Gabor
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.38 |
Book Value | $0.04 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
